SCHEMBL12893120

SCHEMBL12893120

CCCCCCCCCCCC[N+](C)(CCCC)Cc1ccc2oc(-c3ccc(N(CC)CC)cc3)c(O)c(=O)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 2/20 0.43
▸ MAPT P10636 8/20 0.42
▸ KDM4E B2RXH2 7/20 0.42
▸ CYP3A4 P08684 7/20 0.42
▸ MEN1 O00255 6/20 0.42
▸ KMT2A Q03164 6/20 0.42
▸ HSD17B10 Q99714 5/20 0.42
▸ CYP2C9 P11712 2/20 0.42
▸ TP53 P04637 7/20 0.41
▸ RXFP1 Q9HBX9 2/20 0.41
▸ CSNK2A2 P19784 3/20 0.40
▸ CSNK2B P67870 3/20 0.40
▸ CSNK2A1 P68400 3/20 0.40
▸ LMNA P02545 2/20 0.36
▸ RET P07949 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ ALOX12 P18054 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ MKNK2 Q9HBH9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12918131 0.93 ABCB1 (0.40) ABCB1MAPTKDM4ECYP3A4MEN1
SCHEMBL12893115 0.90 ABCB1 (0.38) ABCB1MAPTKDM4ECYP3A4MEN1
SCHEMBL2323461 0.81 ABCB1 (0.45) ABCB1MAPTKDM4ECYP3A4MEN1
SCHEMBL1259555 0.79 MAPT (0.51) ABCB1MAPTKDM4ECYP3A4MEN1
SCHEMBL2329785 0.75 MAPT (0.42) ABCB1MAPTKDM4ECYP3A4MEN1
SCHEMBL19833677 0.72 TP53 (0.67) ABCB1MAPTKDM4ECYP3A4MEN1
SCHEMBL30888820 0.72 TP53 (0.67) ABCB1MAPTKDM4ECYP3A4MEN1
SCHEMBL17940134 0.71 MAPT (0.49) ABCB1MAPTKDM4ECYP3A4MEN1
SCHEMBL17353582 0.68 MAPT (0.53) ABCB1MAPTKDM4ECYP3A4MEN1
SCHEMBL14697042 0.65 MEN1 (0.61) ABCB1MAPTKDM4ECYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7880021-B2 reacting 6-bromomethyl-4'-(diethylamino)-3-hydroxyflavone with dodecylmethylamine to form the corresponding tertiary amine (4'-(diethylamino)-6-(dodecyl(methyl)aminomethyl)-3-hydroxyflavone); and reacting the product of step a. with propansultone; use in biomembrane studies; Alzheimer's disease, cancer CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2011-02-01 — — US disclosed
Send feedback